Skip to main content
SpringerLink
Log in

Neuro-Behçet’s Disease: Epidemiology and Genetics

  • Chapter
  • First Online:
Neuro-Behçet’s Disease

  • 246 Accesses

Abstract

Behçet’s disease (BD) is a chronic inflammatory disorder affecting multiple systems in the body. Neuro-Behçet’s disease (NBD) is the neurological manifestation of BD. It usually occurs late in the disease and tends to affect 10–30% of BD patients. The neurological symptoms may include cerebral thrombosis in the arterial or venous systems, meningoencephalitis, demyelination, memory loss, and behavioral changes. Although BD cases have been reported from all over the world, it is more common in the geographical regions on the historic Silk Route. The highest prevalence of the disease is in Turkey. It mostly affects individuals between 20 and 40 years of age and affects men and women equally. BD etiology has not been well understood yet, but various genetic, environmental, and immunological factors are thought to play a role. Although the human leukocyte antigen (HLA)-B51 has long been suggested to be the dominant predisposing factor in BD, the non-major histocompatibility complex (MHC) class I genes have been associated with BD susceptibility as well. The genome-wide association studies (GWAS) reported various single-nucleotide polymorphism of certain genes in BD. Additionally, targeted next-generation sequencing methods have demonstrated non-synonymous variants (NSVs). The epigenetics (interspersed repetitive sequences, miRNAs) of BD and NBD have also been of interest to the researchers lately. Even though the studies primarily focus on BD rather than NBD, the data gathered for BD has been expected to be compatible with NBD etiopathogenesis. Further NBD-oriented epidemiologic, genetic, and epigenetic studies are needed to enlighten the disease etiology and to detect differential NBD biomarkers.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Eraksoy M, Akman-Demir G. Merkezi sinir sisteminin miyelin hastalıkları. In: Nöroloji. 2nd ed. İstanbul: Nobel Tıp Kitabevleri; 2015. p. 626–7. Retrieved from http://www.itfnoroloji.org/MS/MS.htm.

    Google Scholar 

  2. International Study Group for Behçet’s Disease. Criteria for diagnosis of Behcet’s disease. Lancet. 1990;335(8697):1078–80. https://doi.org/10.1016/0140-6736(90)92643-V.

    Article  Google Scholar 

  3. Akman-Demir G, Saip S, Siva A. Behçet’s disease. Curr Treat Options Neurol. 2011;13(3):290–310. https://doi.org/10.1007/s11940-011-0120-2.

    Article  PubMed  Google Scholar 

  4. Saadoun D, Wechsler B, Desseaux K, Le Thi Huong D, Amoura Z, Resche-Rigon M, Cacoub P. Mortality in Behçet’s disease. Arthritis Rheum. 2010;62(9):2806–12. https://doi.org/10.1002/art.27568.

    Article  CAS  PubMed  Google Scholar 

  5. Al-Araji A, Kidd DP. Neuro-Behçet’s disease: epidemiology, clinical characteristics, and management. Lancet Neurol. 2009;8(2):192–204. https://doi.org/10.1016/S1474-4422(09)70015-8.

    Article  PubMed  Google Scholar 

  6. Haghighi AB, Pourmand R, Nikseresht AR. Neuro-Behçet disease: a review. Neurologist. 2005;11(2):80–9. https://doi.org/10.1097/01.nrl.0000156343.16797.c4.

    Article  Google Scholar 

  7. Kaufman WS, Mcnamara EK, Jorizzo JL. Behçet’s disease. In: Kelley’s textbook of rheumatology, vol. 9(93); 2012. p. 1589. https://doi.org/10.1016/B978-1-4377-1738-9.00093-1.

    Chapter  Google Scholar 

  8. Verity DH, Wallace GR, Vaughan RW, Stanford MR. Behçet’s disease: from Hippocrates to the third millennium. Br J Ophthalmol. 2003;87(9):1175–83.

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Ozlu E, Uzuncakmak T. Epidemiology and genetic aspects of Behçet’s disease. In: Behcet’s disease – a compilation of recent research and review studies: SM Group; 2017. p. 1–8.

    Google Scholar 

  10. Oguz I, Hizli P, Gonul M. The epidemiology of Behçet’s disease. In: Behcet’s disease: InTech; 2017. p. 15–26. https://doi.org/10.5772/68055.

  11. Gönül M, Kartal SP. Introductory chapter: Behcet’s disease – an overview. In: Behcet’s disease: InTech; 2017. https://doi.org/10.5772/intechopen.69050.

  12. Joseph FG, Scolding NJ. Neuro-Behçet’s disease in Caucasians: a study of 22 patients. Eur J Neurol. 2007;14(2):174–80. https://doi.org/10.1111/j.1468-1331.2006.01613.x.

    Article  CAS  PubMed  Google Scholar 

  13. Saip S, Akman-Demir G, Siva A. Neuro-Behcet syndrome. Handb Clin Neurol. 2014;121:1703–23. https://doi.org/10.1016/b978-0-7020-4088-7.00110-3.

    Article  PubMed  Google Scholar 

  14. Lakhanpal S, Tani K, Lie JT, Katoh K, Ishigatsubo Y, Ohokubo T. Pathologic features of Behçet’s syndrome: a review of Japanese autopsy registry data. Hum Pathol. 1985;16(8):790–5. https://doi.org/10.1016/S0046-8177(85)80250-1.

    Article  CAS  PubMed  Google Scholar 

  15. Kural-seyahi E, Fresko I, Seyahi N, Ozyazgan Y, Mat C, Hamuryudan V, Yurdakul S, Yazici H. The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore). 2003;82(1):60–76.

    Google Scholar 

  16. Chessa Ricotti G, De Martino M, Martini R, Rossi ME, Pietraperzia M, Vierucci A. A case of Behcet’s disease in a child: clinical, genetic, and immunologic characteristics. Pediatr Med Chir. 1983;5(4):211–8. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/6647083.

    CAS  PubMed  Google Scholar 

  17. Koné-Paut I. Behçet’s disease in children, an overview. Pediatr Rheumatol. 2016;14(1):10. https://doi.org/10.1186/s12969-016-0070-z.

    Article  Google Scholar 

  18. Mora P, Menozzi C, Orsoni JG, Rubino P, Ruffini L, Carta A. Neuro-Behçet’s disease in childhood: a focus on the neuro-ophthalmological features. Orphanet J Rare Dis. 2013;8:18. https://doi.org/10.1186/1750-1172-8-18.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Sefidbakht S, Babaeinejad M, Jali R, Zare Z, Sahraian A, Safari A, Haghighi AB. The McDonald criteria for dissemination in space in the differential diagnosis of multiple sclerosis and neuro-Behcet’s disease. Neurol Asia. 2014;19(2):47–52.

    Google Scholar 

  20. Yalçin B. Major histocompatibility complex (MHC) molecules: their common characteristics and relations with diseases. Turkderm Deri Hastaliklari ve Frengi Arsivi. 2013;47(1):12–7. https://doi.org/10.4274/turkderm.47.s2.

    Article  Google Scholar 

  21. Kidd D, Steuer A, Denman AM, Rudge P. Neurological complications in Behçet’s syndrome. Brain. 1999;122(11):2183–94.

    PubMed  Google Scholar 

  22. Akman-Demir G, Serdaroglu P, Tasci B. Clinical patterns of neurological involvement in Behçet’s disease : evaluation of 200 patients. Brain. 1999;122:2171–81.

    PubMed  Google Scholar 

  23. Shinkeigaku R. Central nervous system involvement in Behçet’s disease. Rinsho Shinkeigaku. 2001;41(12):1147–9.

    Google Scholar 

  24. Hisanaga K. Neuro-neutrophilic disease: neuro-Behçet disease and neuro-sweet disease. Intern Med. 2007;46(4):153–4. https://doi.org/10.2169/internalmedicine.46.0175.

    Article  PubMed  Google Scholar 

  25. Esatoglu SN, Kutlubay Z, Ucar D, Hatemi I, Uygunoglu U, Siva A, Hatemi G. Behçet’s syndrome: providing integrated care. J Multidiscip Healthc. 2017;10:309–19. https://doi.org/10.2147/JMDH.S93681.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Noel N, Bernard R, Wechsler B, Resche-Rigon M, Depaz R, Le Thi Huong Boutin D, Piette JC, Drier A, Dormont D, Cacoub P, Saadoun D. Long-term outcome of neuro-behçet’s disease. Arthr Rheumatol. 2014;66(5):1306–14. https://doi.org/10.1002/art.38351.

    Article  Google Scholar 

  27. Demirseren D, Ceylan G, Akoglu G, Emre S, Erten S, Arman A, Metin A. HLA-B51 subtypes in Turkish patients with Behçet’s disease and their correlation with clinical manifestations. Genet Mol Res. 2014;13(133):4788–96. https://doi.org/10.4238/2014.July.2.8.

    Article  CAS  PubMed  Google Scholar 

  28. Maenaka K, Maenaka T, Tomiyama H, Takiguchi M, Stuart DI, Jones EY. Nonstandard peptide binding revealed by crystal structures of Hla-B5101 complexed with HIV immunodominant epitopes. J Immunol. 2000;165:3260. https://doi.org/10.2210/PDB1E28/PDB.

    Article  CAS  PubMed  Google Scholar 

  29. Hatemi G, Seyahi E, Fresko I, Talarico R, Hamuryudan V. One year in review 2016: Behçet’s syndrome. Clin Exp Rheumatol. 2016;102:10–22.

    Google Scholar 

  30. Wei F, Zhang Y, Li W. A meta-analysis of the association between Behçet’s disease and MICA-A6. Biomed Rep. 2016;4(6):741–5. https://doi.org/10.3892/br.2016.644.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Lee YH, Song GG. Associations between major histocompatibility complex class I chain-related gene A polymorphisms and susceptibility to Behcet’s disease. A meta-analysis. Z Rheumatol. 2015;74(8):714–21. https://doi.org/10.1007/s00393-014-1536-3.

    Article  CAS  PubMed  Google Scholar 

  32. Jorde LB, Wooding SP. Genetic variation, classification and “race”. Nat Genet. 2004;36(11s):S28–33. https://doi.org/10.1038/ng1435.

    Article  CAS  PubMed  Google Scholar 

  33. Takeuchi M, Kastner DL, Remmers EF. The immunogenetics of Behçet’s disease: a comprehensive review. J Autoimmun. 2015;64:137–48. https://doi.org/10.1016/j.jaut.2015.08.013.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Mizuki N, Meguro A, Ota M, Ohno S, Shiota T, Kawagoe T, Ito N, Kera J, Okada E, Yatsu K, Song YW, Lee EB, Kitaichi N, Namba K, Horie Y, Takeno M, Sugita S, Mochizuki M, Bahram S, Ishigatsubo Y, Inoko H. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behçet’s disease susceptibility loci. Nat Genet. 2010;42(8):703–6. https://doi.org/10.1038/ng.624.

    Article  CAS  PubMed  Google Scholar 

  35. Remmers EF, Cosan F, Kirino Y, Ombrello MJ, Abaci N, Satorius C, Le JM, Yang B, Korman BD, Cakiris A, Aglar O, Emrence Z, Azakli H, Ustek D, Tugal-Tutkun I, Akman-Demir G, Chen W, Amos CI, Dizon MB, Akdag Kose A, Azizlerli G, Erer B, Brand OJ, Kaklamani VG, Kaklamanis P, Ben-Chetrit E, Stanford M, Fortune F, Ghabra M, Ollier WER, Cho YH, Bang D, O’Shea J, Wallace GR, Gadina M, Kastner DL, Gül A. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet’s disease. Nat Genet. 2010;42(8):698–702. https://doi.org/10.1038/ng.625.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Wu Z, Zheng W, Xu J, Sun F, Chen H, Li P, Chen S, Shen M, Zhang W, You X, Wu Q, Zhang F, Li Y. IL10 polymorphisms associated with Behçet’s disease in Chinese Han. Hum Immunol. 2014;75(3):271–6. https://doi.org/10.1016/j.humimm.2013.11.009.

    Article  CAS  PubMed  Google Scholar 

  37. Lee YJ, Horie Y, Wallace GR, Choi YS, Park JA, Choi JY, Park JA, Choi JY, Song R, Kang YM, Kang SW, Baek H, Kitaichi N, Meguro A, Mizuki N, Namba K, Ishida S, Kim J, Niemczyk E, Lee EY, Song YW, Ohno S, Lee EB. Genome-wide association study identifies GIMAP as a novel susceptibility locus for Behçet’s disease. Ann Rheum Dis. 2013;72(9):1510–6. https://doi.org/10.1136/annrheumdis-2011-200288.

    Article  CAS  PubMed  Google Scholar 

  38. Kirino Y, Zhou Q, Ishigatsubo Y, Mizuki N, Tugal-Tutkun I, Seyahi E, Özyazgan Y, Ugurlu S, Erer B, Abaci N, Ustek D, Meguro A, Ueda A, Takeno M, Inoko H, Ombrello MJ, Satorius CL, Maskeri B, Mullikin JC, Sun HW, Gutierrez-Cruz G, Kim Y, Wilson AF, Kastner DL, Gül A, Remmers EF. Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Behcet disease. Proc Natl Acad Sci. 2013;110(20):8134–9. https://doi.org/10.1073/pnas.1306352110.

    Article  PubMed  Google Scholar 

  39. Hou S, Yang Z, Du L, Jiang Z, Shu Q, Chen Y, Li F, Zhou Q, Ohno S, Chen R, Kijlstra A, Rosenbaum JT, Yang P. Identification of a susceptibility locus in STAT4 for Behçet’s disease in Han Chinese in a genome-wide association study. Arthritis Rheum. 2012;64(12):4104–13. https://doi.org/10.1002/art.37708.

    Article  CAS  PubMed  Google Scholar 

  40. Qin J, Li L, Zhang D, Yu H, Tan H, Zhang J, Deng B, Kijlstra A, Yang P. Analysis of receptor tyrosine kinase genetics identifies two novel risk loci in GAS6 and PROS1 in Behçet’s disease. Sci Rep. 2016;6(1):26662. https://doi.org/10.1038/srep26662.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Qin X, Xu J, Wu Z, Sun F, Chen H, Zheng W, Li S, Li P, Chen S, Shen M, Zhang W, You X, Wu Q, Zhang F, Li Y z. Association study of rs924080 and rs11209032 polymorphisms of IL23R-IL12RB2 in a Northern Chinese Han population with Behcet’s disease. Hum Immunol. 2016;77(12):1284–90. https://doi.org/10.1016/j.humimm.2016.09.006.

    Article  CAS  PubMed  Google Scholar 

  42. Xavier JM, Shahram F, Sousa I, Davatchi F, Matos M, Abdollahi BS, Sobral J, Nadji A, Oliveira M, Ghaderibarim F, Shafiee NM, Mojarad N. FUT2: filling the gap between genes and environment in Behçet’s disease. Ann Rheum Dis. 2015;74:618–24. https://doi.org/10.1136/annrheumdis-2013-204475.

    Article  CAS  PubMed  Google Scholar 

  43. Alipour S, Nouri M, Sakhinia E, et al. Epigenetic alterations in chronic disease focusing on Behçet’s disease: review. Biomed Pharmacother. 2017;91:526–33. https://doi.org/10.1016/j.biopha.2017.04.106.

  44. Chang JT, Shevach EM, Segal BM. Regulation of interleukin (IL)-12 receptor β2 subunit expression by endogenous IL-12: a critical step in the differentiation of pathogenic autoreactive T cells. J Exp Med. 1999;189(6):969–78. https://doi.org/10.1084/jem.189.6.969.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Gheita TA, Gamal SM, Shaker I, El Fishawy HS, El Sisi R, Shaker OG, Kenawy SA. Clinical significance of serum interleukin-23 and A/G gene (rs17375018) polymorphism in Behçets disease: relation to neuro-Behçet, uveitis and disease activity. Joint Bone Spine. 2015;82(3):213–5. https://doi.org/10.1016/j.jbspin.2014.10.008.

    Article  CAS  PubMed  Google Scholar 

  46. Steinman L. Mixed reesults with modulation of T H-17 cells in human autoimmune diseases. Nat Immunol. 2010;11:41–4. Nature Publishing Group. https://doi.org/10.1038/ni.1803.

    Article  CAS  PubMed  Google Scholar 

  47. Çavuş F, Ulusoy C, Örçen A, Gül A, Tüzün E, Vural B. Increased IL-23 receptor, TNF-α and IL-6 expression in individuals with the IL23R-IL12RB2 locus polymorphism. Immunol Lett. 2014;160(1):96–8. https://doi.org/10.1016/j.imlet.2014.01.001.

    Article  CAS  PubMed  Google Scholar 

  48. Morton LT, Situnayake D, Wallace GR. Genetics of Behçet’s disease. Curr Opin Rheumatol. 2016;28(1):39–44. https://doi.org/10.1097/BOR.0000000000000234.

    Article  CAS  PubMed  Google Scholar 

  49. Wolf SF, Sieburth D, Sypek J. Interleukin 12: a key modulator of immune function. Stem Cells. 1994;12(2):154–68. https://doi.org/10.1002/stem.5530120203.

    Article  CAS  PubMed  Google Scholar 

  50. Kappen JH, Medina-Gomez C, Van Hagen PM, Stolk L, Estrada K, Rivadeneira F, Uitterlinden AG, Stanford MR, Ben-Chetrit E, Wallace GR, Soylu M, Van Laar JAM. Genome-wide association study in an admixed case series reveals IL12A as a new candidate in Behçet disease. PLoS One. 2015;10(3):e0119085. https://doi.org/10.1371/journal.pone.0119085.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Sousa I, Shahram F, Francisco D, Davatchi F, Abdollahi BS, Ghaderibarmi F, Nadji A, Shafiee NM, Xavier JM, Oliveira SA. Brief report: association of CCR1, KLRC4, IL12A-AS1, STAT4, and ERAP1 with Behçet’s disease in Iranians. Arthr Rheumatol (Hoboken, NJ). 2015;67(10):2742–8. https://doi.org/10.1002/art.39240.

    Article  Google Scholar 

  52. Ortiz-Fernández L, Carmona FD, Montes-Cano MA, García-Lozano JR, Conde-Jaldón M, Ortego-Centeno N, Castillo MJ, Espinosa G, Graña-Gil G, Sánchez-Bursón J, Juliá MR, Solans R, Blanco R, Barnosi-Marín AC, De la Torre RG, Fanlo P, Rodríguez-Carballeira M, Rodríguez-Rodríguez L, Camps T, Castañeda S, Alegre-Sancho JJ, Martín J, González-Escribano MF. Genetic analysis with the immunochip platform in Behçet disease. Identification of residues associated in the HLA class I region and new susceptibility loci. PLoS One. 2016;11(8):e0161305. https://doi.org/10.1371/journal.pone.0161305.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Yazici H. Behçet’s syndrome in the 2000s: “where is the wisdom we have lost in knowledge?”. Clin Exp Rheumatol. 2016;34:23–5.

    PubMed  Google Scholar 

  54. Wallace GR. HLA-B*51 the primary risk in Behçet disease. Proc Natl Acad Sci U S A. 2014;111(24):8706–7. https://doi.org/10.1073/pnas.1407307111.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. Goswami R, Kaplan MH. STAT transcription factors in T cell control of health and disease. In: International review of cell and molecular biology, vol. 31: Academic Press; 2017. p. 123–80. https://doi.org/10.1016/bs.ircmb.2016.09.012.

  56. Kirino Y, Bertsias G, Ishigatsubo Y, Mizuki N, Tugal-Tutkun I, Seyahi E, Ozyazgan Y, Sacli FS, Erer B, Inoko H, Emrence Z, Cakar A, Abaci N, Ustek D, Satorius C, Ueda A, Takeno M, Kim Y, Wood GM, Ombrello MJ, Meguro A, Gül A, Remmers EF, Kastner DL. Genome-wide association analysis identifies new susceptibility loci for Behçet’s disease and epistasis between HLA-B*51 and ERAP1. Nat Genet. 2013;45(2):202–7. https://doi.org/10.1038/ng.2520.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Hou S, Xiao X, Li F, Jiang Z, Kijlstr A, Yang P. Two-stage association study in Chinese Han identifies two independent associations in CCR1/CCR3 locus as candidate for Behçet’s disease susceptibility. Hum Genet. 2012;131(12):1841–50. https://doi.org/10.1007/s00439-012-1200-4.

    Article  CAS  PubMed  Google Scholar 

  58. Boone DL, Turer EE, Lee EG, Ahmad RC, Wheeler MT, Tsui C, Hurley P, Chien M, Chai S, Hitotsumatsu O, McNally E, Pickart C, Ma A. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol. 2004;5(10):1052–60. https://doi.org/10.1038/ni1110.

    Article  CAS  PubMed  Google Scholar 

  59. Zhou Q, Wang H, Schwartz DM, Stoffels M, Hwan Park Y, Zhang Y, Yang D, Demirkaya E, Takeuchi M, Tsai WL, Lyons JJ, Yu X, Ouyang C, Chen C, Chin DT, Zaal K, Chandrasekharappa SC, Hanson EP, Yu Z, Mullikin JC, Hasni SA, Wertz IE, Ombrello AK, Stone DL, Hoffmann P, Jones A, Barham BK, Leavis HL, Van Royen-Kerkof A, Sibley C, Batu ED, Gül A, Siegel RM, Boehm M, Milner JD, Ozen S, Gadina M, Chae J, Laxer RM, Kastner DL, Aksentijevich I. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease. Nat Genet. 2015;48(1):67–73. https://doi.org/10.1038/ng.3459.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  60. Li H, Liu Q, Hou S, Du L, Zhou Q, Zhou Y, Kijlstra A, Li Z, Yang P. TNFAIP3 gene polymorphisms confer risk for Behcet’s disease in a Chinese Han population. Hum Genet. 2013;132(3):293–300. https://doi.org/10.1007/s00439-012-1250-7.

    Article  CAS  PubMed  Google Scholar 

  61. Ortiz-Fernandez L, García-Lozano JR, Montes-Cano MA, Conde-Jaldon M, Ortego-Centeno N, Garcia-Hernandez FJ, Espinosa G, Graña-Gil G, Sánchez-Bursón J, Juliá MR, Blanco R, Barnosi-Marín AC, Solans R, Fanlo P, Rodríguez Carballeira M, Camps T, Castañeda S, Martín J, González-Escribano MF. Lack of association of TNFAIP3 and JAK1 with Behçet’s disease in the European population. Clin Exp Rheumatol. 2015;33(6, supl.94):S36–9. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26005883

    PubMed  Google Scholar 

  62. Di Marzio P, Dai WW, Franchin G, Chan AY, Symons M, Sherry B. Role of Rho family GTPases in CCR1- and CCR5-induced actin reorganization in macrophages. Biochem Biophys Res Commun. 2005;331(4):909–16. https://doi.org/10.1016/J.BBRC.2005.04.015.

    Article  PubMed  Google Scholar 

  63. Karasneh J, Gu A, Ollier WE, Silman AJ, Worthington J. Whole-genome screening for susceptibility genes in multicase families with Behçet’s disease. Arthr Rheumatol. 2005;52(6):1836–42. https://doi.org/10.1002/art.21060.

    Article  CAS  Google Scholar 

  64. Ciucci T, Bosselut R. Gimap and T cells: a matter of life or death. Eur J Immunol. 2014;44(2):348–51. https://doi.org/10.1002/eji.201344375.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  65. Ferrer-Admetlla A, Sikora M, Laayouni H, Esteve A, Roubinet F, Blancher A, Calafell F, Bertranpetit J, Casals F. A natural history of FUT2 polymorphism in humans. Mol Biol Evol. 2009;26(9):1993–2003. https://doi.org/10.1093/molbev/msp108.

    Article  CAS  PubMed  Google Scholar 

  66. Archer DA, Graham ME, Burgoyne RD. Complexin regulates the closure of the fusion pore during regulated vesicle exocytosis. J Biol Chem. 2002;277(21):18249–52. https://doi.org/10.1074/jbc.C200166200.

    Article  CAS  PubMed  Google Scholar 

  67. Uğurel E, Şehitoğlu E, Tüzün E, Kürtüncü M, Çoban A, Vural B. Increased complexin-1 and decreased miR-185 expression levels in Behçet’s disease with and without neurological involvement. Neurol Sci. 2016;37(3):411–6. https://doi.org/10.1007/s10072-015-2419-3.

    Article  PubMed  Google Scholar 

  68. Fei Y, Webb R, Cobb BL, Direskeneli H, Saruhan-Direskeneli G, Sawalha AH. Identification of novel genetic susceptibility loci for Behçet’s disease using a genome-wide association study. Arthritis Res Ther. 2009;11(3):R66. https://doi.org/10.1186/ar2695.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Hou S, Yang P, Du L, Zhou H, Lin X, Liu X, Kijlstra A. SUMO4 gene polymorphisms in Chinese Han patients with Behcet’s disease. Clin Immunol. 2008;129(1):170–5. https://doi.org/10.1016/j.clim.2008.06.006.

    Article  CAS  PubMed  Google Scholar 

  70. Kim J, Im CH, Kang EH, Lee EY, Lee YJ, Park KS, Song YW. Mannose-binding lectin gene-2 polymorphisms and serum mannose-binding lectin levels in Behçet’s disease. Clin Exp Rheumatol. 2009;27(2):S13–7.

    CAS  PubMed  Google Scholar 

  71. Boiardi L, Salvarani C, Casali B, Olivieri I, Ciancio G, Cantini F, Salvi F, Malatesta R, Govoni M, Trotta F, Filippini D, Paolazzi G, Nicoli D, Farnetti E, Macchioni L. Intercellular adhesion molecule-1 gene polymorphisms in Behçet’s disease. J Rheumatol. 2001;28(6):1283–7. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11409120.

    CAS  PubMed  Google Scholar 

  72. Pulsatelli L. Vascular endothelial growth factor gene polymorphisms in Behçet’s disease. J Rheumatol. 2004;31(9):1785–9.

    PubMed  Google Scholar 

  73. Burillo-Sanz S, Montes-Cano M-A, García-Lozano J-R, Ortiz-Fernández L, Ortego-Centeno N, García-Hernández F-J, Espinosa G, Graña-Gil G, Sánchez-Bursón J, Juliá MR, Solans R, Blanco R, Barnosi-Marín AC, De la Torre RG, Fanlo P, Rodríguez-Carballeira M, Rodríguez-Rodríguez L, Camps T, Castañeda S, Alegre-Sancho JJ, Martín J, González-Escribano MF. Mutational profile of rare variants in inflammasome-related genes in Behçet disease: a next generation sequencing approach. Sci Rep. 2017;7(1):8453. https://doi.org/10.1038/s41598-017-09164-7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. Wu Z, Zhang S, Li J, Chen S, Li P, Sun F, Wen X, Zheng W, Zhang F, Li Y. Association between MEFV mutations M694V and M680I and Behçet’s disease: a meta-analysis. PLoS One. 2015;10(7):e0132704. https://doi.org/10.1371/journal.pone.0132704.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Okabe K, Izumi Y, Miyashita T, Irino K, Kawahara C, Jiuchi Y, Nonaka F, Eguchi K, Kawakami A, Migita K. An usual case of vasculo- and neuro-Behçet’s disease with MEFV mutations. JPN J Clin Immunol. 2014;37(1):61–7. https://doi.org/10.2177/jsci.37.61.

    Article  CAS  Google Scholar 

  76. Yüksel Ş, Kucukazman SO, Karataş GS, Ozturk MA, Prombhul S, Hirankarn N. Methylation status of Alu and LINE-1 interspersed repetitive sequences in Behcet’s disease patients. Biomed Res Int. 2016;2016:1–9. https://doi.org/10.1155/2016/1393089.

    Article  CAS  Google Scholar 

  77. Alipour S, Nouri M, Sakhinia E, Samadi N, Roshanravan N, Ghavami A, Khabbazi A. Epigenetic alterations in chronic disease focusing on Behçet’s disease: review. Biomed Pharmacother. 2017;91:526–33. https://doi.org/10.1016/j.biopha.2017.04.106.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neuroscience, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey

    Hande Yüceer & Erdem Tüzün

Authors
  1. Hande Yüceer
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Erdem Tüzün
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Istanbul University, Istanbul, Turkey

    Erdem Tüzün

  2. Istanbul University, Istanbul, Turkey

    Murat Kürtüncü

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Yüceer, H., Tüzün, E. (2021). Neuro-Behçet’s Disease: Epidemiology and Genetics. In: Tüzün, E., Kürtüncü, M. (eds) Neuro-Behçet’s Disease. Springer, Cham. https://doi.org/10.1007/978-3-030-55273-2_1

Download citation

Publish with us

Policies and ethics

Search

Navigation